摘要
目的探讨介入治疗耐多药肺结核的临床疗效。方法对2008年6月～2012年2月收治的120例耐多药肺结核患者的临床资料进行回顾性分析。结果两组患者治疗3个月及6个月后,其痰菌阴转率、病灶吸收(空洞闭合缩小)好转率及症状改善有效率等方面差异明显,存在统计学意义(P<0.05)。结论对耐多药肺结核患者给予纤维支气管镜介入治疗,可有效控制结核,提高临床疗效。
Objective To observe the curative effect of interventional therapy treating multidrug-resistant tuberculosis. Methods The clinical data and treatment methods of 120 patients with multidrug-resistant tuberculosis treated in our hospital from June 2008 to February 2012 were analyzed retrospectively. Results There was evident difference between 2 groups in sputum negative conversion rate, focus absorption or cavity narrowing recovery rate and symptoms improved efficiency 3 months and 6 months after receiving treatment, which had statistical significance （P〈0.05）. Conclusion Interventional therapy of fibrobronchoscope to treat patients with multidrug-resistant tuberculosis can control tuberculosis effectively and improve the clinical efficacy.
出处
《当代医学》
2013年第1期48-49,共2页
Contemporary Medicine
关键词
耐多药肺结核
纤维支气管镜
介入治疗
疗效
Multidrug-resistant tuberculosis
Fibrobronchoscope
Interventional therapy
Curative effect
